benefits of glp 1 beyond weight loss The GLP-1 Therapy: GLP-1-based therapies for diabetes, obesity

In certain embodiments, any controlled-release otic formulation described herein increases the exposure of an active agent and increases the Area Under the Curve (AUC) in otic fluids (e.g., endolymph and/or perilymph) by about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, about 100%, or higher than 100%, compared to an otic formulation that is not a controlled-release otic formulation

It could contribute to hypoglycemia

Pack of 2: the pack of 2 contains 2 cans of L-carnitine, each with 150 capsules = 300 capsules total

The rate of congenital malformations (4.3%) was similar to the rate in the general population

The epidemiology of coronary artery disease in patients on maintenance hemodialysis: implications for management